Biosocial Methods Collaborative

New Models. New Perspectives. New Discoveries.

  • About
    • Core Faculty and Staff
    • Contact
  • Membership
  • Resources
  • Lab
  • Events
  • Active Projects
  • Emerging Impact
  • News

Member in the News Thomas Shanley

March 24, 2015 – Multiplex Serum Cytokine Immunoassay Using Nanoplasmonic Biosensor Microarrays

Precise monitoring of the rapidly changing immune status during the course of a disease requires multiplex analysis of cytokines from frequently sampled human blood. However, the current lack of rapid, multiplex, and low volume assays makes immune monitoring for clinical decision-making (e.g., critically ill patients) impractical. Without such assays, immune monitoring is even virtually impossible for infants and neonates with infectious diseases and/or immune mediated disorders as access to their blood in large quantities is prohibited. Localized surface plasmon resonance (LSPR)-based microfluidic optical biosensing is a promising approach to fill this technical gap as it could potentially permit real-time refractometric detection of biomolecular binding on a metallic nanoparticle surface and sensor miniaturization, both leading to rapid and sample-sparing analyte analysis. Despite this promise, practical implementation of such a microfluidic assay for cytokine biomarker detection in serum samples has not been established primarily due to the limited sensitivity of LSPR biosensing. Here, we developed a high-throughput, label-free, multiarrayed LSPR optical biosensor device with 480 nanoplasmonic sensing spots in microfluidic channel arrays and demonstrated parallel multiplex immunoassays of six cytokines in a complex serum matrix on a single device chip while overcoming technical limitations. The device was fabricated using easy-to-implement, one-step microfluidic patterning and antibody conjugation of gold nanorods (AuNRs). When scanning the scattering light intensity across the microarrays of AuNR ensembles with dark-field imaging optics, our LSPR biosensing technique allowed for high-sensitivity quantitative cytokine measurements at concentrations down to 5–20 pg/mL from a 1 μL serum sample. Using the nanoplasmonic biosensor microarray device, we demonstrated the ability to monitor the inflammatory responses of infants following cardiopulmonary bypass (CPB) surgery through tracking the time-course variations of their serum cytokines. The whole parallel on-chip assays, which involved the loading, incubation, and washing of samples and reagents, and 10-fold replicated multianalyte detection for each sample using the entire biosensor arrays, were completed within 40 min.

News

In the News: George Michailidis

In the News: Jan Van den Bulck

In the News: Stephanie Cook

In the News: Hallie Prescott and Theodore Iwashyna

In the News: Julie Lumeng

Home Sweet HomeLab: Studying Daily Life in Context

2018 MCUAAAR Summer Workshops Announced

Member in the News: Fabian Pfeffer

In the News: Ashley Gearhardt

In the News: Michael Zochowski

Archive

Bio-Social Methods Collaborative

Research Center for Group Dynamics

Institute for Social Research

© 2013 The Regents of the University of Michigan

426 Thompson Street
P.O. Box 1248
Ann Arbor, MI 48106
isr-biosocial@umich.edu

University of Michigan Institute for Social Research
University of Michigan Medical School
University of Michigan Life Sciences Institute